journal
MENU ▼
Read by QxMD icon Read
search

Journal of Family Practice

journal
https://www.readbyqxmd.com/read/29989621/thrombocytopenia-and-neutropenia-a-structured-approach-to-evaluation
#1
Richard W Temple, Brittany Burns
These algorithms and tables will help you quickly assess the severity of the 2 blood abnormalities and delineate between life-threatening and benign causes.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989620/how-best-to-manage-chronic-cholestasis
#2
Ignazio Grattagliano, Annarosa Floreani, Enzo Ubaldi, Piero Portincasa
Here's how to maximize your use of lab work and imaging techniques to identify the source of your patient's cholestasis and provide prompt treatment.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989619/clinical-inquiries-what-are-the-benefits-risks-of-giving-betamethasone-to-women-at-risk-of-late-preterm-labor
#3
Lee Dresang, Christopher Hooper-Lane
Giving betamethasone to women at risk for delivery between 34 weeks 0 days and 36 weeks 6 days can lower by almost 40% the incidence of transient tachypnea of the newborn, severe respiratory distress syndrome, and the use of surfactant (strength of recommendation [SOR]: A, systematic review of randomized controlled trials [RCTs]). Betamethasone may increase neonatal hypoglycemia, but the hypoglycemia isn't associated with a prolonged hospital stay or other negative outcomes.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989618/clinical-inquiries-can-cbt-effectively-treat-adult-insomnia-disorder
#4
Steven Fox, Joan Nashelsky, Michael Jack
Yes. Cognitive behavioral therapy (CBT) administered individually, in a group setting, or on the internet is effective for treating insomnia in adults compared with control (strength of recommendation [SOR]: A, meta-analyses). CBT is comparable to pharmacotherapy for improving measures of sleep (SOR: A, comparative meta-analysis). CBT produces sustainable improvements in subjective sleep quality for adults with comorbid insomnia (SOR: A, meta-analysis).
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989617/photo-rounds-pain-in-right-shoulder
#5
Barbara Kiersz
This patient's joint pain kept her out of work for several years. While x-rays of her hands appeared normal, an x-ray of her shoulder exposed the underlying problem.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989616/body-wide-pruritic-papular-rash-%C3%A2-scalp-lesion-%C3%A2-excoriation-%C3%A2-dx
#6
Richard Temple, Theodore Rogers
No abstract text is available yet for this article.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989615/purl-first-time-mild-diverticulitis-antibiotics-or-watchful-waiting
#7
Bob Marshall, Shailendra Prasad, Mary A Noel, Jeffrey Burket, Michael Arnold, Benjamin Arthur, Nick Bennett, Ashley Smith
Don't jump to antibiotic Tx for mild, uncomplicated diverticulitis, a recent RCT says. Observation may be just as effective.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989614/dietary-recommendations-for-patients-with-diabetes
#8
Doug C Outcalt
A new UK guideline bolsters recommendations from the American Diabetes Association and cites newer evidence of diabetes remission through weight loss.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989613/gun-addiction
#9
W E Feeman
No abstract text is available yet for this article.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989612/the-problem-with-blood-pressure-guidelines
#10
EDITORIAL
Paul A James
No abstract text is available yet for this article.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989611/diabetes-in-the-elderly-matching-meds-to-needs
#11
Barbara Keber, Jennifer Fiebert
Elderly patients, whose insulin resistance is complicated by age-related loss of beta-cell function and concomitant diseases, require personalized Tx considerations.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29989610/blood-pressure-targets-how-low-should-you-go-and-for-whom
#12
Eric J MacLaughlin, John F Slaton, Rodney B Young, Sondra M DePalma
The ACC/AHA's lower BP goals are supported by previously unavailable evidence, the strongest of which is for patients with CVD. But others can benefit, too.
July 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29912999/implications-of-cardiovascular-outcomes-trials-in-type-2-diabetes-for-primary-care
#13
Jeff Unger
Patients with type 2 diabetes (T2D) are at a greater risk of cardiovascular (CV) morbidity and mortality than their counterparts without diabetes. Worsening glycemic control is associated with increasing risk of CV events and mortality, but glycemic control alone does not appear sufficient to improve CV outcomes. Furthermore, some glucose-lowering drugs have been associated with an increased risk of CV events. As a result, the US Food and Drug Administration (FDA) issued guidance in 2008 for the investigation of CV risk with new diabetes therapies...
June 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29912998/safety-of-once-weekly-glucagon-like-peptide-1-receptor-agonists-in-patients-with-type-2-diabetes
#14
Juan P Frias
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been found efficacious in the treatment of type 2 diabetes (T2D), demonstrating the ability to lower HbA1c, and having the potential for inducing weight loss and reducing the risk of hypoglycemia, compared with other antihyperglycemic agents. Currently, 4 once-weekly (OW) GLP-1 RAs are approved: albiglutide, dulaglutide, exenatide ER, and recently, semaglutide. This review compares the relative safety of OW GLP-1 RAs, as well as their safety in comparison to other antihyperglycemic agents, using safety data reported in key sponsor-led phase 3 studies of the 4 OW GLP-1 RAs...
June 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29912997/clinical-efficacy-of-once-weekly-glucagonlike-peptide-1-receptor-agonists-in-patients-with-type-2-diabetes
#15
Timothy S Bailey
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are indicated for restoring normoglycemia in patients with type 2 diabetes (T2D). This review analyzed and compared the efficacy results from 30 trials with the once-weekly (OW) GLP-1 RAs albiglutide, dulaglutide, exenatide extended-release (ER) and semaglutide. The 4 OW GLP-1 RAs showed a higher reduction in glycated hemoglobin (HbA1c), fasting plasma glucose (FPG) and body weight, when compared to placebo. Semaglutide significantly reduced the HbA1c level (estimated treatment difference [ETD]: -0...
June 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29912996/the-pharmacokinetic-properties-of-glucagon-like-peptide-1-receptor-agonists-and-their-mode-and-mechanism-of-action-in-patients-with-type-2-diabetes
#16
John Anderson
Once-weekly (OW) glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated improved glycemic control in patients with type 2 diabetes (T2D), and some have a number of other benefits, including weight loss, improvements in blood pressure and lipid profiles, and cardiovascular protection. They also provide a therapy option with a low risk of hypoglycemia, an attractive choice for many patients. Molecular structure and pharmacokinetic properties vary among GLP-1 RAs, with some more closely related than others to native glucagon-like peptide-1 (GLP-1)...
June 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29912995/an-overview-of-the-burden-of-illness-and-the-role-of-once-weekly-glucagon-like-peptide-1-receptor-agonists-in-the-treatment-of-type-2-diabetes
#17
Stephen A Brunton
Type 2 diabetes (T2D) is a debilitating condition and more people are being diagnosed each year. T2D increases patients' risk of developing disabling micro- and macrovascular complications, significantly reduces patients' quality of life, and is a substantial global economic burden. The efficacy and safety of antihyperglycemic therapies have improved over the years and have increased the lifespan for these patients. Consequently, patients are living longer with the condition and the associated comorbidities, but with a lowered quality of life...
June 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29912994/a-clinical-overview-of-once-weekly-glucagon-like-peptide-1-receptor-agonists
#18
Jeff Unger
No abstract text is available yet for this article.
June 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29879245/history-of-posttraumatic-stress-disorder-%C3%A2-priapism-%C3%A2-dx
#19
Caleb Dickison, Chuck A Venable
A 35-year-old African-American man, who was an active duty service member, presented to the Troop Medical Clinic with a 4-hour history of priapism. He had been taking sertraline 100 mg and prazosin 10 mg nightly for 4 months to treat his posttraumatic stress disorder (PTSD) with no reported adverse effects. These doses were titrated 2 months prior to presentation. The patient reported that he took his usual medication doses before bed and awoke at 3 am with a penile erection. At 7 am, he presented to the clinic because of pain from the continued erection...
June 2018: Journal of Family Practice
https://www.readbyqxmd.com/read/29879244/is-the-breast-is-best-mantra-an-oversimplification
#20
Joseph L Wilson, Bridgid H Wilson
Recommendations about breastfeeding--absent critical analysis and removed from context--may overvalue its benefit. Here's a look at the evidence.
June 2018: Journal of Family Practice
journal
journal
20262
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"